Devex 40d ago

In this segment of This Week in Development, sponsored by PATH, Alan Robbins, cofounder and executive vice president of Devex, sits down with Dr. Melanie Saville, PATH’s chief scientific officer and a leading virologist, to discuss why diagnostics receive a mere 2%–3% of global health R&D funding despite being critical to global health infrastructure. Saville highlights how closing the diagnostic gap for just six tracer conditions, including HIV, TB, and syphilis, could prevent over 1 million premature deaths annually in low- and middle-income countries. She also shares key takeaways from a high-level roundtable co-convened with Wellcome, Unitaid, and MedAccess, explaining how gathering robust data on manufacturing and delivery costs is the missing link to unlocking vital capital from development finance institutions and impact investors. For more international development news, visit: http://www.devex.com Subscribe to the Devex YouTube channel: http://www.youtube.com/subscription_center?add_user=wwwdevexcom Follow us on: Facebook: @Devex Instagram: @devex_com LinkedIn: @Devex